Table of Contents Author Guidelines Submit a Manuscript
International Journal of Rheumatology
Volume 2017 (2017), Article ID 7687053, 8 pages
https://doi.org/10.1155/2017/7687053
Clinical Study

Effect of Curcuma xanthorrhiza Supplementation on Systemic Lupus Erythematosus Patients with Hypovitamin D Which Were Given Vitamin D3 towards Disease Activity (SLEDAI), IL-6, and TGF-β1 Serum

1Rheumatology and Immunology Division, Department of Internal Medicine, Faculty of Medicine, Brawijaya University and Saiful Anwar General Hospital, Malang, Indonesia
2Department of Internal Medicine, Faculty of Medicine, Brawijaya University and Saiful Anwar Hospital, Malang, Indonesia
3Pharmacology Department, Faculty of Medicine, Brawijaya University, Malang, Indonesia
4Clinical Pathology Department, Faculty of Medicine, Brawijaya University, Saiful Anwar General Hospital, Malang, Indonesia

Correspondence should be addressed to Handono Kalim; moc.liamg@333milakh

Received 8 May 2017; Revised 13 September 2017; Accepted 25 September 2017; Published 28 December 2017

Academic Editor: Charles J. Malemud

Copyright © 2017 C. Singgih Wahono et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. IRA, Diagnosis dan Pengelolaan Lupus Eritematosus Sistemik, 2011.
  2. K. Shah, W. Lee, S. Lee et al., “Dysregulated balance of Th17 and Th1 cells in systemic lupus erythematosus,” Arthritis Research & Therapy, vol. 12, no. 2, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Dolff, M. Bijl, M. G. Huitema, P. C. Limburg, C. G. M. Kallenberg, and W. H. Abdulahad, “Disturbed Th1, Th2, Th17 and Treg balance in patients with systemic lupus erythematosus,” Clinical Immunology, vol. 141, no. 2, pp. 197–204, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. G. Ruiz-Irastorza, M. V. Egurbide, N. Olivares, A. Martinez-Berriotxoa, and C. Aguirre, “Vitamin D deficiency in systemic lupus erythematosus: Prevalence, predictors and clinical consequences,” Rheumatology, vol. 47, no. 6, pp. 920–923, 2008. View at Publisher · View at Google Scholar · View at Scopus
  5. G. Ruiz-Irastorza, S. Gordo, N. Olivares, M.-V. Egurbide, and C. Aguirre, “Changes in vitamin D levels in patients with systemic lupus erythematosus: Effects on fatigue, disease activity, and damage,” Arthritis Care & Research, vol. 62, no. 8, pp. 1160–1165, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Puspitasari, H. Kalim, A. Rudijanto, and C. S. Wahono, Korelasi kadar vitamin D serum dengan aktivitas penyakit pasien Lupus Eritematosus Sistemik (SLEDAI), Universitas Brawijaya, Malang, Indonesia, 2012.
  7. S. M. A. Toloza, D. E. C. Cole, D. D. Gladman, D. Ibañez, and M. B. Urowitz, “Vitamin D insufficiency in a large female SLE cohort,” Lupus, vol. 19, no. 1, pp. 13–19, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. T. J. O'Leary, G. Jones, A. Yip, D. Lohnes, M. Cohanim, and E. R. Yendt, “The effects of chloroquine on serum 1,25-dihydroxyvitamin D and calcium metabolism in sarcoidosis,” The New England Journal of Medicine, vol. 315, no. 12, pp. 727–730, 1986. View at Publisher · View at Google Scholar · View at Scopus
  9. J. F. Carvalho, M. Blank, E. Kiss, T. Tarr, H. Amital, and Y. Shoenfeld, “Anti-vitamin D, vitamin D in SLE: preliminary results,” Annals of the New York Academy of Sciences, vol. 1109, pp. 550–557, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Handono, D. Hasanah, H. Kalim, and H. Mawarti, “The association among serum levels of vitamin D, TGf-ß/IL-6 balance and Treg/Th17 balance in systemic lupus erythematosus patients in Indonesia,” International Journal of Biochemistry and Biotechnology, vol. 2, pp. 490–496, 2013. View at Google Scholar
  11. A. Rifai, CS. Wahono, and H. Kalim, The effect of Vitamin D3 supplementation toward disease activity and fatigue in SLE patients with hypovitamin D, Brawijaya University, Malang, Indonesia, 2014.
  12. M. Barreto, R. C. Ferreira, L. Lourenço et al., “Low frequency of CD4+CD25+ Treg in SLE patients: A Heritable trait associated with CTLA4 and TGFβ gene variants,” BMC Immunology, vol. 10, no. 1, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. J. J. Bright, “Curcumin and autoimmune disease,” in The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease, pp. 425–451, Springer, 2007. View at Google Scholar
  14. M. R. Haussler, C. A. Haussler, L. Bartik et al., “Vitamin D receptor: Molecular signaling and actions of nutritional ligands in disease prevention,” Nutrition Reviews, vol. 66, no. 2, pp. S98–S112, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. L. Bartik, G. K. Whitfield, M. Kaczmarska et al., “Curcumin: a novel nutritionally derived ligand of the vitamin D receptor with implications for colon cancer chemoprevention,” The Journal of Nutritional Biochemistry, vol. 21, no. 12, pp. 1153–1161, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Z. Pratama, C. S. Wahono, K. Handono et al., “Immune supression effects of curcumin in pristane induced lupus mice,” International Journal of Rheumatic Disease, 2015. View at Google Scholar
  17. P. Khajehdehi, B. Zanjaninejad, E. Aflaki et al., “Oral supplementation of turmeric decreases proteinuria, hematuria, and systolic blood pressure in patients suffering from relapsing or refractory lupus nephritis: a randomized and placebo-controlled study,” Journal of Renal Nutrition, vol. 22, no. 1, pp. 50–57, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. A. C. Ross, C. L. Taylor, A. L. Yaktine, and H. B. Del Valle, Food and Nutrition Board. Institute of Medicine. Dietary Reference Intakes for Calcium and Vitamin D, National Academy Press, Washington, DC, USA, 2011.
  19. L. Van Groningen, S. Opdenoordt, A. Van Sorge, D. Telting, A. Giesen, and H. De Boer, “Cholecalciferol loading dose guideline for vitamin D-deficient adults,” European Journal of Endocrinology, vol. 162, no. 4, pp. 805–811, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. NHS, Guidelines for the Prescribing of Vitamin D in Adults, 2013.
  21. J. J. Cannell, B. W. Hollis, M. Zasloff, and R. P. Heaney, “Diagnosis and treatment of vitamin D deficiency,” Expert Opinion on Pharmacotherapy, vol. 9, no. 1, pp. 107–118, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Abou-Raya, S. Abou-Raya, and M. Helmii, “The effect of vitamin D supplementation on inflammatory and hemostatic markers and disease activity in patients with systemic lupus erythematosus: a randomized placebo-controlled trial,” The Journal of Rheumatology, vol. 40, no. 3, pp. 265–272, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. M. Petri, K. J. Bello, H. Fang, and L. S. Magder, “Vitamin D in systemic lupus erythematosus: modest association with disease activity and the urine protein-to-creatinine ratio,” Arthritis & Rheumatology, vol. 65, no. 7, pp. 1865–1871, 2013. View at Publisher · View at Google Scholar · View at Scopus
  24. H. Karimzadeh, M. Shirzadi, and M. Karimifar, “The effect of Vitamin D supplementation in disease activity of systemic lupus erythematosus patients with Vitamin D deficiency: A randomized clinical trial,” Journal of Research in Medical Sciences, vol. 22, no. 1, 2017. View at Publisher · View at Google Scholar
  25. P. E. Spronk, E. J. Borg, P. C. LImburgf, and C. G. Kallenberg, “Plasma concentration of IL-6 in systemic lupus erythematosus; an indicator of disease activity?” Clinical & Experimental Immunology, vol. 90, no. 1, pp. 106–110, 1992. View at Publisher · View at Google Scholar
  26. Cytokines and Systemic Lupus Erythematosus, http://www.intechopen.com.
  27. L. Nonn, L. Peng, D. Feldman, and D. M. Peehl, “Inhibition of p38 by vitamin D reduces interleukin-6 production in normal prostate cells via mitogen-activated protein kinase phosphatase 5: implications for prostate cancer prevention by vitamin D,” Cancer Research, vol. 66, no. 8, pp. 4516–4524, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. L. Non, D. Duong, and D. M. Peehl, “Chemopreventive anti-inflammatory activities of curcumin and other phytochemicals mediated by MAP kinase phosphatase-5 in prostate cells,” Carcinogenesis, vol. 28, no. 6, pp. 1188–1196, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Jäger, R. P. Lowery, A. V. Calvanese, J. M. Joy, M. Purpura, and J. M. Wilson, “Comparative absorption of curcumin formulations,” Nutrition Journal , vol. 13, article 11, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. B. B. Aggarwal, Y.-J. Surh, and S. Shishodia, The Molecular Targets and Therapeutic Uses of Curcumin in Health and Disease, vol. 595, Springer Science & Business Media, 2007.
  31. D. Menegaz, M. T. Mizwicki, A. Barrientos-Duran, N. Chen, H. L. Henry, and A. W. Norman, “Vitamin d receptor (VDR) regulation of voltage-gated chloride channels by ligands preferring a VDR-alternative pocket (VDR-AP),” Molecular Endocrinology, vol. 25, no. 8, pp. 1289–1300, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Guo, E. Rosoha, M. B. Lowry, N. Borregaard, and A. F. Gombart, “Curcumin induces human cathelicidin antimicrobial peptide gene expression through a vitamin D receptor-independent pathway,” The Journal of Nutritional Biochemistry, vol. 24, no. 5, pp. 754–759, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. P. Anand, A. B. Kunnumakkara, R. A. Newman, and B. B. Aggarwal, “Bioavailability of curcumin: problems and promises,” Molecular Pharmaceutics, vol. 4, no. 6, pp. 807–818, 2007. View at Publisher · View at Google Scholar · View at Scopus
  34. A. Jacob, R. Wu, M. Zhou, and P. Wang, “Mechanism of the anti-inflammatory effect of curcumin: PPAR-γ activation,” PPAR Research, vol. 2007, Article ID 89369, 5 pages, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. V. R. Narala, M. R. Smith, R. K. Adapala et al., “Curcumin is not a ligand for peroxisome proliferator-activated receptor-γ,” Gene therapy & molecular biology, vol. 13, no. 1, pp. 20–25, 2009. View at Google Scholar · View at Scopus
  36. Z. Adhya, S. Borozdenkova, and M. Y. Karim, “The role of cytokines as biomarkers in systemic lupus erythematosus and lupus nephritis,” Nephrology Dialysis Transplantation , vol. 26, no. 10, pp. 3273–3280, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. K. Ohtsuka, J. D. Gray, M. M. Stimmler, B. Toro, and D. A. Horwitz, “Decreased production of TGF-β by lymphocytes from patients with systemic lupus erythematosus,” The Journal of Immunology, vol. 160, no. 5, pp. 2539–2545, 1998. View at Google Scholar · View at Scopus
  38. N. Mo, Z.-Q. Li, J. Li, and Y.-D. Cao, “Curcumin inhibits TGF-beta1-induced MMP-9 and invasion through ERK and smad signaling in breast cancer MDA-MB-231 cells,” Asian Pacific Journal of Cancer Prevention, vol. 13, no. 11, pp. 5709–5714, 2012. View at Publisher · View at Google Scholar · View at Scopus